The first DICE Therapeutics trade was made in Q4 2021.
Since then Ken Griffin bought shares three more times and sold shares on four occasions. The investor completely sold their stake between Q2 2023 and Q3 2023.
Avg closing price
Price range
Sold -869 shares
Q3 2023
Avg closing price
$46.90
Price range
$46.40
-
$47.55
Sold 99.6% shares (-201 Thousand shares)
Q2 2023
Avg closing price
$34.56
Price range
$25.86
-
$46.71
Increased shares by 35.1% (+52.5 Thousand shares)
Q1 2023
Avg closing price
$29.62
Price range
$26.05
-
$32.31
Sold 75.3% shares (-456 Thousand shares)
Q4 2022
Avg closing price
$32.61
Price range
$19.77
-
$42.23
Sold 34.5% shares (-319 Thousand shares)
Q3 2022
Avg closing price
$18.22
Price range
$14.97
-
$22.65
Increased shares by 710.5% (+810 Thousand shares)
Q2 2022
Avg closing price
$17.20
Price range
$13.19
-
$22.10
Increased shares by 4.2% (+4.63 Thousand shares)
Q1 2022